RX COMPLIANCE REPORT

Rx Compliance Report, now in its tenth year of publication, is the only news source exclusively devoted to the government's crackdown on pharmaceutical sales and marketing practices. This 16-page bi-weekly newsletter examines emerging investigations and offers practical firsthand advice on implementing effective compliance programs. Rx Compliance Report focuses on the state and federal agencies leading these fraud and abuse investigations including the U.S. Dept. of Justice, the HHS Office of Inspector General (OIG), state Attorneys General, state Medicaid Fraud Control Units, and the Securities and Exchange Commission. Readers include legal, regulatory, and compliance officers from nearly every major pharmaceutical company, as well as numerous biotech and medical device companies. Most of the top 40 drug companies and numerous law firms license the newsletter on a company-wide basis.

SUBSCRIPTION RATES:

Rx Compliance Report is available at the low annual rate of $797 (24 issues/year). Click here to subscribe.

Multi-issue discounts and licensing agreements are also available. Click here for more.

TOPICS:

  • Off-label promotion
  • Continuing medical education
  • Direct-to-Consumer (DTC) advertising
  • Drug pricing (Best price, AWP, Medicaid drug rebates)
  • False Claims Act strategic defenses
  • HIPAA/privacy


  • Social media/Internet promotion
  • Sales force training
  • Sample accountability/PDMA
  • Foreign Corrupt Practice Act/Global Investigations
  • Monitoring and auditing
  • Compliance program development

  • EDITORIAL ADVISORY BOARD:
    • Ted Acosta, Principal, Ernst & Young, Former Senior Attorney, HHS Office of Inspector General, New York, NY
    • Ken Berkowitz, Senior Consultant, The PharMed Group, Former Assistant General Counsel, Hoffman LaRoche, Former President, HMC Council, Tenafly, NJ
    • Regina Cavaliere, Chief Compliance Officer & Vice President, Otsuka American Pharmaceutical, Princeton, NJ
    • Eve Costopoulos, Vice President, Chief Ethics & Compliance Officer, Eisai Inc., Woodcliff Lake, NJ
    • Marc Farley, Vice President, Health Care Compliance, DePuy, Inc. - A Johnson & Johnson Company, New Brunswick, NJ, Former Assistant US Attorney, District of NJ, New Brunswick, NJ
    • Laurence Freedman, Partner, Patton Boggs, Washington, DC, Former Assistant Director, Fraud Section, Commercial Litigation Branch, Civil Division, US Dept of Justice, Washington, DC
    • John Kamp, Executive Director, Healthcare Communications Council, New York, NY
    • Daniel Kracov, Chair, Pharmaceutical & Medical Device Practice, Arnold & Porter, Washington, DC
    • Marc Raspanti, Partner, Pietragallo Gordon Alfano Bosick & Raspant, Philadelphia PA
    • William Sarraille, Partner, Sidley Austin, Washington DC
    • Paul Silver, Practice Leader, Huron Consulting Group, Atlanta, GA
    • Michael Shaw, Vice President & Compliance Officer, GlaxoSmithKline-NA Pharmaceuticals, Former Senior Counsel, HHS Office of Inspector General, Philadelphia, PA

    HOW TO ORDER:

    To order, please choose one of the following options:
    • One-year subscription -- $797 (24 issues) -- click here

    • Multi-issue discounts and licensing agreements -- click here
    Note: Rx Compliance Report is delivered in PDF-version only




    Sample Issue | Order Now | Resources | Testimonials | Past Issues | Copyright Policy | Contact Us

    All material on this website is protected by copyright.
    © Rx Compliance Report.
    All rights reserved.